MaxCyte Return on Equity

MaxCyte (MXCT) currently reports a ROE of -22.45%. That is below the Materials sector average of 19.44%. Use the charts on this page to explore MaxCyte's ROE history and peer comparisons.

MaxCyte's ROE of -22.45% is lower than the Materials sector average of 19.44%. That is roughly 215.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but MaxCyte's current -22.45% should be judged against Materials norms (sector average: 19.44%) and against MXCT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -22.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 19.44%. From there, open related valuation or income-statement pages for MaxCyte, and consider following MXCT for alerts when major investors trade the stock.

MaxCyte is classified in the Materials sector. On ROE, it currently shows -22.45% versus a sector average near 19.44%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing MXCT with unrelated industries.